Have you ever felt that nagging sense that everyone is piling into the same hot trend, only to wonder what happens when the music stops? That’s exactly the feeling many investors are experiencing right now with artificial intelligence stocks. As global tech shares take a hit and chipmakers lead the declines, one experienced fund manager is quietly suggesting it’s time to look elsewhere for real opportunities.
I’ve followed market rotations for years, and they rarely announce themselves with fanfare. Instead, they creep in during moments of uncertainty, rewarding those willing to step away from the crowd. Today, we’re diving deep into the thinking behind shifting away from AI dominance toward sectors that could offer more sustainable growth in the coming years.
Why Smart Money Is Eyeing a Rotation Out of AI
The recent sell-off in global tech stocks hasn’t gone unnoticed. From European bourses to U.S. pre-market action, names tied heavily to semiconductors are feeling the pressure. Intel and Micron are just a couple of the high-profile names showing weakness. In conversations with market professionals, a clear theme emerges: diversification isn’t just nice to have — it’s becoming essential.
Tom Hulick, who runs Strategy Asset Managers as CEO and focuses on large-cap value growth with a quant momentum approach, has been vocal about this shift. He believes retail investors remain fixated on the so-called Magnificent Seven, but the broader market is ready for something different. Small caps could finally have their moment, and certain established players in traditional industries are showing surprising strength.
What makes this rotation particularly interesting is how it ties into longer-term technological progress. While AI grabs headlines, advancements in other fields are happening quietly but powerfully. Perhaps the most compelling part is how these developments build on each other, creating opportunities that many are currently overlooking.
Eli Lilly: A Biotech Powerhouse Poised for Continued Growth
When it comes to sectors that benefit from innovation without being pure AI plays, biotechnology and pharmaceuticals stand out. Eli Lilly has caught the attention of value-oriented managers for good reason. The company isn’t just riding one wave — it’s positioned at the intersection of several powerful trends in healthcare.
Consider the advancements in GLP-1 drugs and weight management treatments. These aren’t fleeting fads. They’re addressing massive global health challenges that affect millions. Hulick pointed out that not enough people are discussing what could come next in pharma, especially as AI tools accelerate drug discovery and development processes.
Innovation’s not going to stop, technology is not going to slow down. That’s the exciting part.
– Fund manager highlighting pharma potential
Looking back five or ten years, the progress in biotech is nothing short of remarkable. New delivery methods, more targeted therapies, and better understanding of human biology are transforming patient outcomes. Eli Lilly’s portfolio reflects this evolution, with treatments that have driven substantial share price appreciation over the past half-decade.
Shares have climbed over 400% in five years, largely thanks to successful weight-loss medications like Mounjaro. Yet this year, the stock has been relatively subdued, up only modestly. That kind of pause after a strong run can sometimes signal a healthy consolidation before the next leg up, especially if upcoming catalysts materialize.
In my experience watching these cycles, companies like Eli Lilly that combine strong fundamentals with innovative pipelines often reward patient investors. The biotech space as a whole looks attractive amid these advancements, offering a blend of growth and, in some cases, reasonable valuations compared to sky-high tech multiples.
- Strong momentum in weight management and diabetes treatments
- AI-enhanced drug development accelerating pipelines
- Global healthcare demands continuing to expand
- Potential for new injection therapies and expanded indications
Of course, no investment is without risks. Regulatory hurdles, competition, and clinical trial outcomes can swing valuations quickly. But for those rotating out of overheated AI names, a name like this provides exposure to tangible innovation with real-world impact today.
GE Vernova: Powering the Future with Earnings Momentum
Energy infrastructure might not sound as glamorous as the latest AI model, but it’s fundamental to everything else. GE Vernova represents a spin-off focused on power systems, renewable integration, and grid modernization — areas seeing consistent demand as economies grow and electrify.
Hulick highlighted the company’s great earnings momentum within the power industry. This isn’t abstract speculation. It’s backed by real needs: aging infrastructure upgrades, increasing electricity demand from data centers and manufacturing, and the transition toward more reliable energy sources.
What I find particularly compelling is how GE Vernova sits at the center of multiple megatrends. Electrification isn’t going away. Whether it’s supporting renewable integration or providing baseload stability, companies that deliver practical power solutions should see steady orders.
Investors chasing pure growth stories sometimes forget that stable, essential services can compound wealth effectively over time. The power sector’s capital-intensive nature creates barriers to entry, potentially protecting margins for established players who execute well.
We’re looking at stocks that are important to the continued growth of the markets.
Beyond immediate earnings, consider the longer horizon. As societies invest more in clean energy and resilient grids, specialized knowledge in turbines, transmission, and related technologies becomes increasingly valuable. GE Vernova’s heritage in this space gives it credentials that newer entrants struggle to match.
Panasonic: Energy Storage and Efficiency Solutions
The third name on the list might surprise some — Panasonic. Known historically for consumer electronics, the company has evolved significantly in areas critical to modern energy management. Backup battery systems and supercapacitors are becoming essential tools as power demands fluctuate.
These technologies help store energy efficiently and manage distribution more intelligently. In a world with more intermittent renewables and higher overall consumption, solutions that smooth out supply are worth their weight in gold. Hulick sees real potential here as markets broaden beyond the usual tech giants.
I’ve always believed that the best investment ideas often hide in plain sight. Panasonic’s work in batteries isn’t just about electric vehicles — it’s about entire energy ecosystems. From residential backup to industrial applications, the versatility stands out.
Supercapacitors add another layer, offering rapid charge and discharge capabilities that complement traditional batteries. This combination could prove crucial for grid stability and specialized uses where speed matters more than raw capacity.
| Sector | Key Driver | Investment Thesis |
| Pharma/Biotech | GLP drugs & innovation | Health megatrends + AI acceleration |
| Power/Energy | Infrastructure needs | Earnings momentum & electrification |
| Energy Storage | Battery tech advances | Grid modernization & efficiency |
Looking at these three together paints a picture of thoughtful diversification. Rather than betting everything on one narrative, this approach spreads exposure across healthcare needs, energy fundamentals, and enabling technologies.
The Broader Market Context and Small Cap Potential
One of the more intriguing comments from the fund manager was the expectation that small caps could pick up steam. For years, mega-cap tech has dominated indices and investor attention. When that concentration eases, capital often flows toward neglected areas of the market.
This rotation doesn’t mean abandoning growth entirely. It means being more selective. Companies with solid earnings trajectories, reasonable valuations, and exposure to enduring trends deserve consideration. The power industry, for instance, benefits from both policy support and organic demand growth.
Retail investors sticking exclusively with the biggest names might miss out on this broadening. History shows that leadership changes create both winners and losers. Those prepared to adjust portfolios accordingly often fare better over full market cycles.
Risks and Considerations for Investors
Let’s be realistic — no strategy is foolproof. Rotating out of AI means potentially missing further upside if enthusiasm returns quickly. Valuations in other sectors aren’t always cheap, and external factors like interest rates, geopolitics, or economic slowdowns can impact all equities.
Pharma faces patent cliffs and pricing pressures in some markets. Energy companies deal with commodity volatility and regulatory shifts. Technology hardware firms encounter supply chain complexities and competitive landscapes that evolve rapidly.
- Assess your overall portfolio allocation before making changes
- Consider time horizon — these ideas suit longer-term thinking
- Stay informed on company-specific developments and earnings
- Remember diversification applies within sectors too
- Consult professional advice tailored to your situation
In my view, the most successful investors combine conviction with flexibility. They recognize when narratives become overcrowded and have the discipline to explore alternatives.
What Advancements in Pharma Really Mean Long Term
It’s worth spending more time on the healthcare side because the implications extend far beyond stock prices. AI is indeed helping accelerate molecule discovery, clinical trial design, and even personalized medicine approaches. But the real breakthroughs often come from combining computational power with human expertise in biology.
Eli Lilly’s success with Mounjaro illustrates how addressing metabolic health can have ripple effects across entire healthcare systems. Reduced complications from obesity and diabetes could lower long-term costs and improve quality of life for countless people. That’s the kind of innovation with staying power.
Looking ahead, expect more convergence between tech and traditional pharma. Companies that embrace these tools while maintaining rigorous scientific standards will likely lead. The five-year chart for Eli Lilly tells a story of remarkable appreciation, but the next chapter could be even more interesting if pipeline deliveries continue.
Energy Transition Meets Practical Reality
GE Vernova and Panasonic both tie into the energy story, but from complementary angles. One focuses on generation and grid infrastructure, while the other emphasizes storage and efficiency. Together, they address the intermittency challenge that has plagued renewable adoption.
Supercapacitors, for instance, excel in applications requiring bursts of power or frequent cycling. Backup systems provide security during outages or peak demand. As data centers proliferate to support AI workloads ironically enough, reliable power becomes non-negotiable.
This creates a fascinating dynamic. AI drives electricity demand higher, which in turn boosts the need for better energy infrastructure and storage. The rotation away from pure AI plays could indirectly benefit companies enabling the entire ecosystem.
Portfolio Construction in a Changing Environment
Building a resilient portfolio today requires thinking beyond daily headlines. While AI will undoubtedly shape the future, it’s not the only game in town. Value growth names with momentum offer a balanced way to participate in progress without paying peak multiples for unproven potential.
Consider how these picks might interact with existing holdings. A tech-heavy portfolio could benefit from adding healthcare stability and industrial exposure. Small cap allocations might complement large cap names if market breadth improves as anticipated.
I’ve seen too many investors chase performance only to suffer when sentiment shifts. The fund manager’s emphasis on broadening out feels timely. Markets rarely move in straight lines, and periods of concentration often precede more distributed returns.
Key Takeaways for Individual Investors
- Diversification matters more than ever in concentrated markets
- Healthcare innovation continues offering compelling long-term stories
- Energy infrastructure benefits from structural demand tailwinds
- Storage technologies are critical enablers for future grids
- Small caps could provide additional alpha if rotation materializes
The beauty of investing lies in connecting dots across seemingly unrelated fields. Pharma advancements, power generation, and battery tech all support modern life in fundamental ways. Recognizing these connections early can position portfolios advantageously.
As we navigate uncertain times with geopolitical tensions, inflation concerns, and technological disruption, having exposure to companies solving real problems feels prudent. Eli Lilly tackles health challenges, GE Vernova keeps the lights on, and Panasonic helps manage energy more effectively.
Looking Ahead: Patience and Perspective
Market rotations test patience. They don’t always deliver immediate results, and there will be periods where the old leaders continue outperforming. But over time, those who position thoughtfully across sectors tend to build more durable wealth.
Keep an eye on earnings reports, management commentary, and macroeconomic indicators. The companies mentioned have strong narratives, but execution will determine ultimate success. In the meantime, use any weakness in AI-related names as an opportunity to rebalance rather than panic.
Ultimately, successful investing combines knowledge, discipline, and a willingness to think independently. While everyone else chases the latest buzz, opportunities exist for those willing to dig deeper into sectors with solid foundations and exciting developments.
The conversation around rotating out of AI isn’t about dismissing its importance. It’s about recognizing that markets work best when capital flows to where it’s most needed and productive. Healthcare, energy, and supporting technologies certainly qualify on both counts.
Whether you’re managing your own portfolio or simply staying informed, understanding these dynamics can make you a more effective investor. The next phase of market leadership might look quite different from the last few years — and that could be very good news for diversified thinkers.
Stay curious, keep learning, and remember that the most rewarding investments often require looking past the obvious. In a world obsessed with AI, sometimes the smartest move is finding strength in other areas that power human progress every single day.
